Symbol:
Cdca8
Name:
cell division cycle associated 8
RGD ID:
1566306
Description:
Predicted to be involved in mitotic metaphase chromosome alignment. Predicted to be located in several cellular components, including chromocenter; midbody; and nuclear lumen. Predicted to be part of chromosome passenger complex. Predicted to be active in chromosome, centromeric region and spindle midzone. Orthologous to human CDCA8 (cell division cycle associated 8); INTERACTS WITH 1-naphthyl isothiocyanate; 17alpha-ethynylestradiol; 17beta-estradiol.
Type:
protein-coding
RefSeq Status:
PROVISIONAL
Previously known as:
borealin; cell division cycle-associated protein 8
RGD Orthologs
Alliance Orthologs
More Info
more info ...
More Info
Latest Assembly:
GRCr8 - GRCr8 Assembly
Position:
Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 142,461,082 - 142,483,336 (-) NCBI GRCr8 mRatBN7.2 5 137,176,414 - 137,198,686 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 137,176,417 - 137,198,629 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 139,879,673 - 139,902,403 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 141,649,678 - 141,672,408 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 141,656,859 - 141,679,587 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 142,911,310 - 142,933,536 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 142,911,305 - 142,933,526 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 146,680,981 - 146,700,067 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 5 144,251,164 - 144,276,352 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 5 135,697,190 - 135,716,709 (-) NCBI Celera Cytogenetic Map 5 q36 NCBI
JBrowse:
View Region in Genome Browser (JBrowse)
Model
Only show annotations with direct experimental evidence (0 objects hidden)
Cdca8 Rat (1->4)-beta-D-glucan multiple interactions ISO Cdca8 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CDCA8 mRNA CTD PMID:36331819 Cdca8 Rat 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane decreases expression ISO CDCA8 (Homo sapiens) 6480464 o and p'-DDT results in decreased expression of CDCA8 mRNA CTD PMID:18204070 Cdca8 Rat 1,1-dichloroethene increases expression ISO Cdca8 (Mus musculus) 6480464 vinylidene chloride results in increased expression of CDCA8 mRNA CTD PMID:26682919 Cdca8 Rat 1,2-dichloroethane decreases expression ISO Cdca8 (Mus musculus) 6480464 ethylene dichloride results in decreased expression of CDCA8 mRNA CTD PMID:28960355 Cdca8 Rat 1,2-dimethylhydrazine multiple interactions ISO Cdca8 (Mus musculus) 6480464 [1 and 2-Dimethylhydrazine co-treated with Folic Acid] results in decreased expression of CDCA8 mRNA CTD PMID:22206623 Cdca8 Rat 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CDCA8 mRNA CTD PMID:30723492 Cdca8 Rat 17alpha-ethynylestradiol increases expression ISO Cdca8 (Mus musculus) 6480464 Ethinyl Estradiol results in increased expression of CDCA8 mRNA CTD PMID:17942748 Cdca8 Rat 17alpha-ethynylestradiol affects expression EXP 6480464 Ethinyl Estradiol affects the expression of CDCA8 mRNA CTD PMID:17351261 Cdca8 Rat 17alpha-ethynylestradiol multiple interactions ISO Cdca8 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDCA8 mRNA CTD PMID:17942748 Cdca8 Rat 17beta-estradiol increases expression ISO Cdca8 (Mus musculus) 6480464 Estradiol results in increased expression of CDCA8 mRNA CTD PMID:25210133 Cdca8 Rat 17beta-estradiol affects expression EXP 6480464 Estradiol affects the expression of CDCA8 mRNA CTD PMID:32145629 Cdca8 Rat 17beta-estradiol increases expression ISO CDCA8 (Homo sapiens) 6480464 Estradiol results in increased expression of CDCA8 mRNA CTD PMID:19167446 Cdca8 Rat 17beta-estradiol multiple interactions ISO Cdca8 (Mus musculus) 6480464 ESR1 protein promotes the reaction [Estradiol results in increased expression of CDCA8 mRNA] CTD PMID:25210133 Cdca8 Rat 2,2',4,4',5,5'-hexachlorobiphenyl multiple interactions ISO Cdca8 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Cdca8 Rat 2,2',4,4'-Tetrabromodiphenyl ether decreases expression EXP 6480464 2 more ... CTD PMID:27291303 Cdca8 Rat 2,2',4,4'-Tetrabromodiphenyl ether decreases expression ISO CDCA8 (Homo sapiens) 6480464 2 more ... CTD PMID:31173147 Cdca8 Rat 2,2',5,5'-tetrachlorobiphenyl multiple interactions ISO Cdca8 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Cdca8 Rat 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO Cdca8 (Mus musculus) 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CDCA8 mRNA and AHR protein inhibits the reaction [Tetrachlorodibenzodioxin results in decreased expression of CDCA8 mRNA] CTD PMID:15034205 and PMID:17942748 Cdca8 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CDCA8 mRNA CTD PMID:34747641 Cdca8 Rat 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO Cdca8 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in decreased expression of CDCA8 mRNA CTD PMID:15034205 Cdca8 Rat 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO Cdca8 (Mus musculus) 6480464 Tetrachlorodibenzodioxin results in increased expression of CDCA8 mRNA CTD PMID:19770486 Cdca8 Rat 2,4-diaminotoluene increases expression ISO Cdca8 (Mus musculus) 6480464 2 and 4-diaminotoluene results in increased expression of CDCA8 mRNA CTD PMID:20713471 Cdca8 Rat 2,4-dibromophenyl 2,4,5-tribromophenyl ether affects expression ISO Cdca8 (Mus musculus) 6480464 2 more ... CTD PMID:38648751 Cdca8 Rat 2-palmitoylglycerol increases expression ISO CDCA8 (Homo sapiens) 6480464 2-palmitoylglycerol results in increased expression of CDCA8 mRNA CTD PMID:37199045 Cdca8 Rat 3,3',4,4',5-pentachlorobiphenyl increases expression EXP 6480464 3 more ... CTD PMID:23196670 Cdca8 Rat 3-chloropropane-1,2-diol increases expression EXP 6480464 alpha-Chlorohydrin results in increased expression of CDCA8 mRNA CTD PMID:38301995 Cdca8 Rat 3-methylcholanthrene increases expression ISO Cdca8 (Mus musculus) 6480464 Methylcholanthrene results in increased expression of CDCA8 mRNA CTD PMID:20713471 Cdca8 Rat 4,4'-sulfonyldiphenol decreases expression ISO Cdca8 (Mus musculus) 6480464 bisphenol S results in decreased expression of CDCA8 mRNA CTD PMID:39298647 Cdca8 Rat 4-hydroxyphenyl retinamide increases expression ISO Cdca8 (Mus musculus) 6480464 Fenretinide results in increased expression of CDCA8 mRNA CTD PMID:28973697 Cdca8 Rat 5-fluorouracil decreases expression ISO CDCA8 (Homo sapiens) 6480464 Fluorouracil results in decreased expression of CDCA8 mRNA CTD PMID:17374387 Cdca8 Rat acetamide increases expression EXP 6480464 acetamide results in increased expression of CDCA8 mRNA CTD PMID:31881176 Cdca8 Rat aflatoxin B1 increases expression ISO Cdca8 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of CDCA8 mRNA CTD PMID:19770486 Cdca8 Rat aflatoxin B1 decreases expression ISO CDCA8 (Homo sapiens) 6480464 Aflatoxin B1 results in decreased expression of CDCA8 mRNA CTD PMID:32234424 Cdca8 Rat aflatoxin B1 increases methylation ISO CDCA8 (Homo sapiens) 6480464 Aflatoxin B1 results in increased methylation of CDCA8 gene CTD PMID:27153756 Cdca8 Rat all-trans-retinoic acid decreases expression ISO CDCA8 (Homo sapiens) 6480464 Tretinoin results in decreased expression of CDCA8 mRNA CTD PMID:23724009 and PMID:33167477 Cdca8 Rat antimycin A increases expression ISO CDCA8 (Homo sapiens) 6480464 Antimycin A results in increased expression of CDCA8 mRNA CTD PMID:33512557 Cdca8 Rat Aroclor 1254 decreases expression ISO Cdca8 (Mus musculus) 6480464 Chlorodiphenyl (54% Chlorine) results in decreased expression of CDCA8 mRNA CTD PMID:23650126 Cdca8 Rat arsenite(3-) multiple interactions ISO CDCA8 (Homo sapiens) 6480464 arsenite promotes the reaction [G3BP1 protein binds to CDCA8 mRNA] CTD PMID:32406909 Cdca8 Rat atrazine increases expression ISO CDCA8 (Homo sapiens) 6480464 Atrazine results in increased expression of CDCA8 mRNA CTD PMID:22378314 Cdca8 Rat azathioprine decreases expression ISO CDCA8 (Homo sapiens) 6480464 Azathioprine results in decreased expression of CDCA8 mRNA CTD PMID:22623647 Cdca8 Rat benzo[a]pyrene decreases expression ISO CDCA8 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of CDCA8 mRNA CTD PMID:20064835 Cdca8 Rat benzo[a]pyrene decreases expression ISO Cdca8 (Mus musculus) 6480464 Benzo(a)pyrene results in decreased expression of CDCA8 mRNA CTD PMID:15034205 more ... Cdca8 Rat benzo[a]pyrene multiple interactions ISO Cdca8 (Mus musculus) 6480464 AHR protein inhibits the reaction [Benzo(a)pyrene results in decreased expression of CDCA8 mRNA] CTD PMID:15034205 Cdca8 Rat benzo[a]pyrene diol epoxide I decreases expression ISO CDCA8 (Homo sapiens) 6480464 7 more ... CTD PMID:19150397 and PMID:20382639 Cdca8 Rat benzo[b]fluoranthene increases expression ISO Cdca8 (Mus musculus) 6480464 benzo(b)fluoranthene results in increased expression of CDCA8 mRNA CTD PMID:26377693 Cdca8 Rat beta-carotene multiple interactions ISO Cdca8 (Mus musculus) 6480464 [BCO1 protein affects the susceptibility to beta Carotene] which affects the expression of CDCA8 mRNA CTD PMID:24657404 Cdca8 Rat beta-naphthoflavone multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDCA8 mRNA CTD PMID:18164116 Cdca8 Rat bis(2-chloroethyl) sulfide decreases expression ISO CDCA8 (Homo sapiens) 6480464 Mustard Gas results in decreased expression of CDCA8 mRNA CTD PMID:25102026 Cdca8 Rat bis(2-ethylhexyl) phthalate increases expression ISO Cdca8 (Mus musculus) 6480464 Diethylhexyl Phthalate results in increased expression of CDCA8 mRNA CTD PMID:34319233 Cdca8 Rat bisphenol A decreases expression ISO CDCA8 (Homo sapiens) 6480464 bisphenol A results in decreased expression of CDCA8 mRNA CTD PMID:19490990 and PMID:29275510 Cdca8 Rat bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CDCA8 mRNA CTD PMID:32145629 Cdca8 Rat bisphenol A affects expression ISO CDCA8 (Homo sapiens) 6480464 bisphenol A affects the expression of CDCA8 mRNA CTD PMID:30903817 Cdca8 Rat bisphenol A decreases methylation ISO Cdca8 (Mus musculus) 6480464 bisphenol A results in decreased methylation of CDCA8 promoter CTD PMID:27312807 Cdca8 Rat bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CDCA8 mRNA CTD PMID:25181051 more ... Cdca8 Rat bisphenol A increases expression ISO CDCA8 (Homo sapiens) 6480464 bisphenol A results in increased expression of CDCA8 protein CTD PMID:23142537 Cdca8 Rat cadmium atom decreases expression ISO CDCA8 (Homo sapiens) 6480464 Cadmium results in decreased expression of CDCA8 mRNA CTD PMID:21120746 Cdca8 Rat cadmium dichloride increases expression ISO CDCA8 (Homo sapiens) 6480464 Cadmium Chloride results in increased expression of CDCA8 mRNA CTD PMID:26472689 Cdca8 Rat calcitriol decreases expression ISO CDCA8 (Homo sapiens) 6480464 Calcitriol results in decreased expression of CDCA8 mRNA CTD PMID:21592394 Cdca8 Rat calcitriol multiple interactions ISO CDCA8 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of CDCA8 mRNA CTD PMID:21592394 Cdca8 Rat carbamazepine affects expression ISO CDCA8 (Homo sapiens) 6480464 Carbamazepine affects the expression of CDCA8 mRNA CTD PMID:25979313 Cdca8 Rat carbon nanotube affects expression ISO Cdca8 (Mus musculus) 6480464 Nanotubes and Carbon affects the expression of CDCA8 mRNA CTD PMID:25554681 Cdca8 Rat carbon nanotube increases expression ISO Cdca8 (Mus musculus) 6480464 Nanotubes and Carbon analog results in increased expression of CDCA8 mRNA CTD PMID:25554681 Cdca8 Rat chlorpyrifos decreases expression ISO Cdca8 (Mus musculus) 6480464 Chlorpyrifos results in decreased expression of CDCA8 mRNA CTD PMID:37019170 Cdca8 Rat choline affects expression ISO CDCA8 (Homo sapiens) 6480464 Choline affects the expression of CDCA8 mRNA CTD PMID:17616785 Cdca8 Rat choline multiple interactions ISO Cdca8 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDCA8 mRNA CTD PMID:20938992 Cdca8 Rat chromium(6+) affects expression ISO Cdca8 (Mus musculus) 6480464 chromium hexavalent ion affects the expression of CDCA8 mRNA CTD PMID:28472532 Cdca8 Rat chromium(6+) multiple interactions ISO CDCA8 (Homo sapiens) 6480464 [zinc chromate results in increased abundance of chromium hexavalent ion] which results in decreased expression of CDCA8 mRNA CTD PMID:38479592 Cdca8 Rat cisplatin multiple interactions ISO CDCA8 (Homo sapiens) 6480464 Cisplatin inhibits the reaction [Piroxicam results in decreased expression of CDCA8 mRNA] CTD PMID:21858171 Cdca8 Rat cisplatin decreases expression ISO Cdca8 (Mus musculus) 6480464 Cisplatin results in decreased expression of CDCA8 mRNA CTD PMID:25270620 Cdca8 Rat cobalt dichloride decreases expression ISO CDCA8 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of CDCA8 mRNA CTD PMID:19320972 and PMID:19376846 Cdca8 Rat copper(II) sulfate decreases expression ISO CDCA8 (Homo sapiens) 6480464 Copper Sulfate results in decreased expression of CDCA8 mRNA CTD PMID:19549813 Cdca8 Rat coumestrol multiple interactions ISO CDCA8 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 more ... CTD PMID:19167446 Cdca8 Rat coumestrol increases expression ISO CDCA8 (Homo sapiens) 6480464 Coumestrol results in increased expression of CDCA8 mRNA CTD PMID:19167446 Cdca8 Rat cyclosporin A decreases expression ISO CDCA8 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of CDCA8 mRNA CTD PMID:19159671 and PMID:21632981 Cdca8 Rat cytarabine decreases expression ISO CDCA8 (Homo sapiens) 6480464 Cytarabine results in decreased expression of CDCA8 mRNA CTD PMID:17374387 Cdca8 Rat DDE increases expression ISO CDCA8 (Homo sapiens) 6480464 Dichlorodiphenyl Dichloroethylene results in increased expression of CDCA8 mRNA CTD PMID:38568856 Cdca8 Rat diallyl trisulfide decreases expression ISO CDCA8 (Homo sapiens) 6480464 diallyl trisulfide results in decreased expression of CDCA8 mRNA CTD PMID:34995734 Cdca8 Rat diazinon increases methylation ISO CDCA8 (Homo sapiens) 6480464 Diazinon results in increased methylation of CDCA8 gene CTD PMID:22964155 Cdca8 Rat dibenz[a,h]anthracene increases expression ISO Cdca8 (Mus musculus) 6480464 1 more ... CTD PMID:26377693 Cdca8 Rat dibutyl phthalate decreases expression EXP 6480464 Dibutyl Phthalate results in decreased expression of CDCA8 mRNA CTD PMID:21266533 Cdca8 Rat dibutyl phthalate decreases expression ISO Cdca8 (Mus musculus) 6480464 Dibutyl Phthalate results in decreased expression of CDCA8 mRNA CTD PMID:21266533 Cdca8 Rat dieldrin increases expression EXP 6480464 Dieldrin results in increased expression of CDCA8 mRNA CTD PMID:23153324 Cdca8 Rat diethyl maleate increases expression EXP 6480464 diethyl maleate results in increased expression of CDCA8 mRNA CTD PMID:21161181 Cdca8 Rat doxorubicin decreases expression ISO CDCA8 (Homo sapiens) 6480464 Doxorubicin results in decreased expression of CDCA8 mRNA CTD PMID:30031762 Cdca8 Rat Enterolactone multiple interactions ISO CDCA8 (Homo sapiens) 6480464 [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in increased expression of CDCA8 mRNA CTD PMID:19167446 Cdca8 Rat folic acid multiple interactions ISO Cdca8 (Mus musculus) 6480464 [1 more ... CTD PMID:20938992 and PMID:22206623 Cdca8 Rat folic acid multiple interactions ISO CDCA8 (Homo sapiens) 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of CDCA8 mRNA CTD PMID:24657277 Cdca8 Rat FR900359 affects phosphorylation ISO CDCA8 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of CDCA8 protein CTD PMID:37730182 Cdca8 Rat hydroxyurea decreases expression ISO CDCA8 (Homo sapiens) 6480464 Hydroxyurea results in decreased expression of CDCA8 mRNA CTD PMID:17374387 Cdca8 Rat indole-3-methanol multiple interactions EXP 6480464 [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CDCA8 mRNA CTD PMID:22129741 Cdca8 Rat L-methionine multiple interactions ISO Cdca8 (Mus musculus) 6480464 [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased expression of CDCA8 mRNA CTD PMID:20938992 Cdca8 Rat lead diacetate increases expression ISO Cdca8 (Mus musculus) 6480464 lead acetate results in increased expression of CDCA8 mRNA CTD PMID:21829687 Cdca8 Rat lead(0) affects expression ISO CDCA8 (Homo sapiens) 6480464 Lead affects the expression of CDCA8 mRNA CTD PMID:28903495 Cdca8 Rat leflunomide decreases expression ISO CDCA8 (Homo sapiens) 6480464 leflunomide results in decreased expression of CDCA8 mRNA CTD PMID:28988120 Cdca8 Rat lidocaine increases expression EXP 6480464 Lidocaine results in increased expression of CDCA8 mRNA CTD PMID:35283115 Cdca8 Rat methamphetamine decreases expression ISO CDCA8 (Homo sapiens) 6480464 Methamphetamine results in decreased expression of CDCA8 mRNA CTD PMID:25290377 Cdca8 Rat methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of CDCA8 mRNA CTD PMID:30467583 Cdca8 Rat methotrexate multiple interactions ISO CDCA8 (Homo sapiens) 6480464 [Folic Acid deficiency co-treated with Methotrexate] results in decreased expression of CDCA8 mRNA CTD PMID:24657277 Cdca8 Rat methotrexate decreases expression ISO CDCA8 (Homo sapiens) 6480464 Methotrexate results in decreased expression of CDCA8 mRNA CTD PMID:24657277 Cdca8 Rat mocetinostat decreases expression ISO CDCA8 (Homo sapiens) 6480464 mocetinostat results in decreased expression of CDCA8 mRNA CTD PMID:26378038 Cdca8 Rat N-methyl-4-phenylpyridinium decreases expression ISO CDCA8 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in decreased expression of CDCA8 mRNA CTD PMID:24810058 Cdca8 Rat N-nitrosodiethylamine increases expression ISO Cdca8 (Mus musculus) 6480464 Diethylnitrosamine results in increased expression of CDCA8 mRNA CTD PMID:17854601 Cdca8 Rat N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with beta-Naphthoflavone] results in increased expression of CDCA8 mRNA and [indole-3-carbinol co-treated with Diethylnitrosamine] results in increased expression of CDCA8 mRNA CTD PMID:18164116 and PMID:22129741 Cdca8 Rat N-nitrosodiethylamine multiple interactions ISO Cdca8 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDCA8 mRNA and RB1 protein inhibits the reaction [Diethylnitrosamine results in increased expression of CDCA8 mRNA] CTD PMID:17854601 and PMID:24535843 Cdca8 Rat N-Nitrosopyrrolidine decreases expression ISO CDCA8 (Homo sapiens) 6480464 N-Nitrosopyrrolidine results in decreased expression of CDCA8 mRNA CTD PMID:32234424 Cdca8 Rat naphthalene increases expression ISO Cdca8 (Mus musculus) 6480464 naphthalene results in increased expression of CDCA8 mRNA CTD PMID:18978301 Cdca8 Rat nickel atom increases expression ISO CDCA8 (Homo sapiens) 6480464 Nickel results in increased expression of CDCA8 mRNA CTD PMID:25583101 Cdca8 Rat niclosamide decreases expression ISO CDCA8 (Homo sapiens) 6480464 Niclosamide results in decreased expression of CDCA8 mRNA CTD PMID:28284560 Cdca8 Rat ochratoxin A increases expression EXP 6480464 ochratoxin A results in increased expression of CDCA8 mRNA CTD PMID:38301995 Cdca8 Rat oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CDCA8 mRNA CTD PMID:25729387 Cdca8 Rat oxaliplatin decreases expression EXP 6480464 oxaliplatin results in decreased expression of CDCA8 mRNA CTD PMID:25729387 Cdca8 Rat ozone decreases expression ISO Cdca8 (Mus musculus) 6480464 Ozone results in decreased expression of CDCA8 mRNA CTD PMID:24336422 Cdca8 Rat ozone multiple interactions ISO Cdca8 (Mus musculus) 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which results in increased expression of CDCA8 mRNA more ... CTD PMID:25658374 more ... Cdca8 Rat palbociclib decreases expression ISO CDCA8 (Homo sapiens) 6480464 palbociclib results in decreased expression of CDCA8 mRNA CTD PMID:22869556 Cdca8 Rat paracetamol increases expression ISO CDCA8 (Homo sapiens) 6480464 Acetaminophen results in increased expression of CDCA8 mRNA CTD PMID:22230336 Cdca8 Rat paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CDCA8 mRNA CTD PMID:33387578 Cdca8 Rat PCB138 multiple interactions ISO Cdca8 (Mus musculus) 6480464 [2 more ... CTD PMID:25510870 Cdca8 Rat pentachlorophenol increases expression ISO Cdca8 (Mus musculus) 6480464 Pentachlorophenol results in increased expression of CDCA8 mRNA CTD PMID:23892564 Cdca8 Rat perfluorooctane-1-sulfonic acid multiple interactions ISO Cdca8 (Mus musculus) 6480464 [perfluorooctane sulfonic acid co-treated with Cellulose] results in increased expression of CDCA8 mRNA CTD PMID:36331819 Cdca8 Rat perfluorooctanoic acid decreases expression ISO CDCA8 (Homo sapiens) 6480464 perfluorooctanoic acid results in decreased expression of CDCA8 mRNA CTD PMID:36326898 Cdca8 Rat phenobarbital increases expression ISO Cdca8 (Mus musculus) 6480464 Phenobarbital results in increased expression of CDCA8 mRNA CTD PMID:20403969 Cdca8 Rat phenobarbital affects expression ISO Cdca8 (Mus musculus) 6480464 Phenobarbital affects the expression of CDCA8 mRNA CTD PMID:23091169 Cdca8 Rat phenobarbital multiple interactions ISO Cdca8 (Mus musculus) 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CDCA8 mRNA CTD PMID:24535843 Cdca8 Rat pirinixic acid multiple interactions ISO Cdca8 (Mus musculus) 6480464 [pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of CDCA8 mRNA CTD PMID:19710929 Cdca8 Rat pirinixic acid increases expression ISO Cdca8 (Mus musculus) 6480464 pirinixic acid results in increased expression of CDCA8 mRNA CTD PMID:18301758 and PMID:23811191 Cdca8 Rat piroxicam multiple interactions ISO CDCA8 (Homo sapiens) 6480464 Cisplatin inhibits the reaction [Piroxicam results in decreased expression of CDCA8 mRNA] CTD PMID:21858171 Cdca8 Rat piroxicam decreases expression ISO CDCA8 (Homo sapiens) 6480464 Piroxicam results in decreased expression of CDCA8 mRNA CTD PMID:21858171 Cdca8 Rat potassium dichromate decreases expression ISO Cdca8 (Mus musculus) 6480464 Potassium Dichromate results in decreased expression of CDCA8 mRNA CTD PMID:23608068 Cdca8 Rat pregnenolone 16alpha-carbonitrile increases expression ISO Cdca8 (Mus musculus) 6480464 Pregnenolone Carbonitrile results in increased expression of CDCA8 mRNA CTD PMID:22698814 Cdca8 Rat propanal decreases expression ISO CDCA8 (Homo sapiens) 6480464 propionaldehyde results in decreased expression of CDCA8 mRNA CTD PMID:26079696 Cdca8 Rat resveratrol multiple interactions ISO CDCA8 (Homo sapiens) 6480464 [Coumestrol co-treated with resveratrol] results in increased expression of CDCA8 mRNA CTD PMID:19167446 Cdca8 Rat resveratrol increases expression ISO CDCA8 (Homo sapiens) 6480464 resveratrol results in increased expression of CDCA8 mRNA CTD PMID:19167446 Cdca8 Rat rotenone increases expression ISO CDCA8 (Homo sapiens) 6480464 Rotenone results in increased expression of CDCA8 mRNA CTD PMID:33512557 Cdca8 Rat silicon dioxide increases expression ISO CDCA8 (Homo sapiens) 6480464 Silicon Dioxide results in increased expression of CDCA8 mRNA CTD PMID:25351596 Cdca8 Rat silicon dioxide increases expression ISO Cdca8 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of CDCA8 mRNA CTD PMID:29341224 Cdca8 Rat sodium arsenite decreases expression ISO CDCA8 (Homo sapiens) 6480464 sodium arsenite results in decreased expression of CDCA8 mRNA CTD PMID:20371982 and PMID:38568856 Cdca8 Rat sodium arsenite increases expression ISO CDCA8 (Homo sapiens) 6480464 sodium arsenite results in increased expression of CDCA8 mRNA CTD PMID:29301061 and PMID:34032870 Cdca8 Rat sodium arsenite decreases expression ISO Cdca8 (Mus musculus) 6480464 sodium arsenite results in decreased expression of CDCA8 mRNA CTD PMID:17998272 Cdca8 Rat Soman increases expression EXP 6480464 Soman results in increased expression of CDCA8 mRNA CTD PMID:19281266 Cdca8 Rat sunitinib decreases expression ISO CDCA8 (Homo sapiens) 6480464 Sunitinib results in decreased expression of CDCA8 mRNA CTD PMID:31533062 Cdca8 Rat T-2 toxin increases expression EXP 6480464 T-2 Toxin results in increased expression of CDCA8 mRNA CTD PMID:26141394 Cdca8 Rat tacrolimus hydrate increases expression ISO Cdca8 (Mus musculus) 6480464 Tacrolimus results in increased expression of CDCA8 mRNA CTD PMID:29362864 Cdca8 Rat Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of CDCA8 mRNA CTD PMID:21515302 Cdca8 Rat testosterone multiple interactions ISO CDCA8 (Homo sapiens) 6480464 [Testosterone co-treated with Calcitriol] results in decreased expression of CDCA8 mRNA CTD PMID:21592394 Cdca8 Rat testosterone decreases expression ISO CDCA8 (Homo sapiens) 6480464 Testosterone results in decreased expression of CDCA8 mRNA CTD PMID:21592394 Cdca8 Rat tetrachloromethane increases expression ISO Cdca8 (Mus musculus) 6480464 Carbon Tetrachloride results in increased expression of CDCA8 mRNA CTD PMID:17484886 more ... Cdca8 Rat thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CDCA8 mRNA CTD PMID:23411599 and PMID:34492290 Cdca8 Rat thiram decreases expression ISO CDCA8 (Homo sapiens) 6480464 Thiram results in decreased expression of CDCA8 mRNA CTD PMID:38568856 Cdca8 Rat titanium dioxide increases expression ISO Cdca8 (Mus musculus) 6480464 titanium dioxide results in increased expression of CDCA8 mRNA CTD PMID:23557971 Cdca8 Rat titanium dioxide decreases methylation ISO Cdca8 (Mus musculus) 6480464 titanium dioxide results in decreased methylation of CDCA8 gene and titanium dioxide results in decreased methylation of CDCA8 promoter alternative form CTD PMID:35295148 Cdca8 Rat titanium dioxide affects expression ISO Cdca8 (Mus musculus) 6480464 titanium dioxide affects the expression of CDCA8 mRNA CTD PMID:17656681 Cdca8 Rat topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in decreased expression of CDCA8 mRNA CTD PMID:25729387 Cdca8 Rat topotecan decreases expression EXP 6480464 Topotecan results in decreased expression of CDCA8 mRNA CTD PMID:25729387 Cdca8 Rat toxaphene decreases expression EXP 6480464 Toxaphene results in decreased expression of CDCA8 mRNA CTD PMID:23153324 Cdca8 Rat trichloroethene increases expression ISO Cdca8 (Mus musculus) 6480464 Trichloroethylene results in increased expression of CDCA8 mRNA CTD PMID:25549359 Cdca8 Rat trichloroethene decreases expression EXP 6480464 Trichloroethylene results in decreased expression of CDCA8 mRNA CTD PMID:33387578 Cdca8 Rat trimellitic anhydride increases expression ISO Cdca8 (Mus musculus) 6480464 trimellitic anhydride results in increased expression of CDCA8 mRNA CTD PMID:19042947 Cdca8 Rat triphenyl phosphate affects expression ISO CDCA8 (Homo sapiens) 6480464 triphenyl phosphate affects the expression of CDCA8 mRNA CTD PMID:37042841 Cdca8 Rat triptonide increases expression ISO Cdca8 (Mus musculus) 6480464 triptonide results in increased expression of CDCA8 mRNA CTD PMID:33045310 Cdca8 Rat trovafloxacin decreases expression ISO Cdca8 (Mus musculus) 6480464 trovafloxacin results in decreased expression of CDCA8 mRNA CTD PMID:35537566 Cdca8 Rat tunicamycin decreases expression ISO Cdca8 (Mus musculus) 6480464 Tunicamycin results in decreased expression of CDCA8 mRNA CTD PMID:17127020 Cdca8 Rat tunicamycin decreases expression ISO CDCA8 (Homo sapiens) 6480464 Tunicamycin results in decreased expression of CDCA8 mRNA CTD PMID:22378314 Cdca8 Rat urethane increases expression ISO CDCA8 (Homo sapiens) 6480464 Urethane results in increased expression of CDCA8 mRNA CTD PMID:28818685 Cdca8 Rat valproic acid increases methylation ISO CDCA8 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of CDCA8 gene CTD PMID:29154799 Cdca8 Rat vincaleukoblastine affects response to substance ISO CDCA8 (Homo sapiens) 6480464 CDCA8 protein affects the susceptibility to Vinblastine CTD PMID:16217747 Cdca8 Rat zidovudine multiple interactions ISO CDCA8 (Homo sapiens) 6480464 [Zidovudine co-treated with IFNA1 protein] results in decreased expression of CDCA8 mRNA CTD PMID:20370541 Cdca8 Rat zinc atom increases expression ISO CDCA8 (Homo sapiens) 6480464 Zinc deficiency results in increased expression of CDCA8 mRNA CTD PMID:22171008 Cdca8 Rat zinc(0) increases expression ISO CDCA8 (Homo sapiens) 6480464 Zinc deficiency results in increased expression of CDCA8 mRNA CTD PMID:22171008 Cdca8 Rat zoledronic acid decreases expression ISO CDCA8 (Homo sapiens) 6480464 zoledronic acid results in decreased expression of CDCA8 mRNA CTD PMID:24714768
(1->4)-beta-D-glucan (ISO) 1,1,1-Trichloro-2-(o-chlorophenyl)-2-(p-chlorophenyl)ethane (ISO) 1,1-dichloroethene (ISO) 1,2-dichloroethane (ISO) 1,2-dimethylhydrazine (ISO) 1-naphthyl isothiocyanate (EXP) 17alpha-ethynylestradiol (EXP,ISO) 17beta-estradiol (EXP,ISO) 2,2',4,4',5,5'-hexachlorobiphenyl (ISO) 2,2',4,4'-Tetrabromodiphenyl ether (EXP,ISO) 2,2',5,5'-tetrachlorobiphenyl (ISO) 2,3,7,8-tetrachlorodibenzodioxine (EXP,ISO) 2,4-diaminotoluene (ISO) 2,4-dibromophenyl 2,4,5-tribromophenyl ether (ISO) 2-palmitoylglycerol (ISO) 3,3',4,4',5-pentachlorobiphenyl (EXP) 3-chloropropane-1,2-diol (EXP) 3-methylcholanthrene (ISO) 4,4'-sulfonyldiphenol (ISO) 4-hydroxyphenyl retinamide (ISO) 5-fluorouracil (ISO) acetamide (EXP) aflatoxin B1 (ISO) all-trans-retinoic acid (ISO) antimycin A (ISO) Aroclor 1254 (ISO) arsenite(3-) (ISO) atrazine (ISO) azathioprine (ISO) benzo[a]pyrene (ISO) benzo[a]pyrene diol epoxide I (ISO) benzo[b]fluoranthene (ISO) beta-carotene (ISO) beta-naphthoflavone (EXP) bis(2-chloroethyl) sulfide (ISO) bis(2-ethylhexyl) phthalate (ISO) bisphenol A (EXP,ISO) cadmium atom (ISO) cadmium dichloride (ISO) calcitriol (ISO) carbamazepine (ISO) carbon nanotube (ISO) chlorpyrifos (ISO) choline (ISO) chromium(6+) (ISO) cisplatin (ISO) cobalt dichloride (ISO) copper(II) sulfate (ISO) coumestrol (ISO) cyclosporin A (ISO) cytarabine (ISO) DDE (ISO) diallyl trisulfide (ISO) diazinon (ISO) dibenz[a,h]anthracene (ISO) dibutyl phthalate (EXP,ISO) dieldrin (EXP) diethyl maleate (EXP) doxorubicin (ISO) Enterolactone (ISO) folic acid (ISO) FR900359 (ISO) hydroxyurea (ISO) indole-3-methanol (EXP) L-methionine (ISO) lead diacetate (ISO) lead(0) (ISO) leflunomide (ISO) lidocaine (EXP) methamphetamine (ISO) methapyrilene (EXP) methotrexate (ISO) mocetinostat (ISO) N-methyl-4-phenylpyridinium (ISO) N-nitrosodiethylamine (EXP,ISO) N-Nitrosopyrrolidine (ISO) naphthalene (ISO) nickel atom (ISO) niclosamide (ISO) ochratoxin A (EXP) oxaliplatin (EXP) ozone (ISO) palbociclib (ISO) paracetamol (EXP,ISO) PCB138 (ISO) pentachlorophenol (ISO) perfluorooctane-1-sulfonic acid (ISO) perfluorooctanoic acid (ISO) phenobarbital (ISO) pirinixic acid (ISO) piroxicam (ISO) potassium dichromate (ISO) pregnenolone 16alpha-carbonitrile (ISO) propanal (ISO) resveratrol (ISO) rotenone (ISO) silicon dioxide (ISO) sodium arsenite (ISO) Soman (EXP) sunitinib (ISO) T-2 toxin (EXP) tacrolimus hydrate (ISO) Tesaglitazar (EXP) testosterone (ISO) tetrachloromethane (ISO) thioacetamide (EXP) thiram (ISO) titanium dioxide (ISO) topotecan (EXP) toxaphene (EXP) trichloroethene (EXP,ISO) trimellitic anhydride (ISO) triphenyl phosphate (ISO) triptonide (ISO) trovafloxacin (ISO) tunicamycin (ISO) urethane (ISO) valproic acid (ISO) vincaleukoblastine (ISO) zidovudine (ISO) zinc atom (ISO) zinc(0) (ISO) zoledronic acid (ISO)
Cellular Component
chromocenter (IEA,ISO) chromosome (IEA) chromosome passenger complex (IBA,IEA,ISO,ISS) chromosome, centromeric region (IBA,IEA,ISO) cytoplasm (IEA) cytoskeleton (IEA) intercellular bridge (IEA,ISO) microtubule cytoskeleton (IEA,ISO) midbody (IEA,ISO) nucleolus (IEA,ISO) nucleoplasm (IEA,ISO) nucleus (IEA) protein-containing complex (IEA,ISO,ISS) spindle (IEA) spindle midzone (IBA)
Cdca8 Rat Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCr8 5 142,461,082 - 142,483,336 (-) NCBI GRCr8 mRatBN7.2 5 137,176,414 - 137,198,686 (-) NCBI mRatBN7.2 mRatBN7.2 mRatBN7.2 Ensembl 5 137,176,417 - 137,198,629 (-) Ensembl mRatBN7.2 Ensembl UTH_Rnor_SHR_Utx 5 139,879,673 - 139,902,403 (-) NCBI Rnor_SHR UTH_Rnor_SHR_Utx UTH_Rnor_SHRSP_BbbUtx_1.0 5 141,649,678 - 141,672,408 (-) NCBI Rnor_SHRSP UTH_Rnor_SHRSP_BbbUtx_1.0 UTH_Rnor_WKY_Bbb_1.0 5 141,656,859 - 141,679,587 (-) NCBI Rnor_WKY UTH_Rnor_WKY_Bbb_1.0 Rnor_6.0 5 142,911,310 - 142,933,536 (-) NCBI Rnor6.0 Rnor_6.0 rn6 Rnor6.0 Rnor_6.0 Ensembl 5 142,911,305 - 142,933,526 (-) Ensembl Rnor6.0 rn6 Rnor6.0 Rnor_5.0 5 146,680,981 - 146,700,067 (-) NCBI Rnor5.0 Rnor_5.0 rn5 Rnor5.0 RGSC_v3.4 5 144,251,164 - 144,276,352 (-) NCBI RGSC3.4 RGSC_v3.4 rn4 RGSC3.4 Celera 5 135,697,190 - 135,716,709 (-) NCBI Celera Cytogenetic Map 5 q36 NCBI
CDCA8 Human Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCh38 1 37,692,516 - 37,709,719 (+) NCBI GRCh38 GRCh38 hg38 GRCh38 GRCh38.p14 Ensembl 1 37,692,481 - 37,709,719 (+) Ensembl GRCh38 hg38 GRCh38 GRCh37 1 38,158,188 - 38,175,391 (+) NCBI GRCh37 GRCh37 hg19 GRCh37 Build 36 1 37,930,746 - 37,947,978 (+) NCBI NCBI36 Build 36 hg18 NCBI36 Build 34 1 37,827,251 - 37,844,482 NCBI Celera 1 36,436,198 - 36,453,412 (+) NCBI Celera Cytogenetic Map 1 p34.3 NCBI HuRef 1 36,275,336 - 36,292,634 (+) NCBI HuRef CHM1_1 1 38,274,230 - 38,291,508 (+) NCBI CHM1_1 T2T-CHM13v2.0 1 37,557,243 - 37,574,423 (+) NCBI T2T-CHM13v2.0
Cdca8 Mouse Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl GRCm39 4 124,812,258 - 124,830,710 (-) NCBI GRCm39 GRCm39 mm39 GRCm39 Ensembl 4 124,812,258 - 124,833,104 (-) Ensembl GRCm39 Ensembl GRCm38 4 124,918,465 - 124,936,917 (-) NCBI GRCm38 GRCm38 mm10 GRCm38 GRCm38.p6 Ensembl 4 124,918,465 - 124,939,311 (-) Ensembl GRCm38 mm10 GRCm38 MGSCv37 4 124,595,709 - 124,614,161 (-) NCBI GRCm37 MGSCv37 mm9 NCBIm37 MGSCv36 4 124,420,769 - 124,439,207 (-) NCBI MGSCv36 mm8 Celera 4 123,240,998 - 123,259,215 (-) NCBI Celera Cytogenetic Map 4 D2.2 NCBI cM Map 4 57.93 NCBI
Cdca8 Chinchilla Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChiLan1.0 Ensembl NW_004955452 15,486,452 - 15,499,867 (+) Ensembl ChiLan1.0 ChiLan1.0 NW_004955452 15,486,515 - 15,501,838 (+) NCBI ChiLan1.0 ChiLan1.0
CDCA8 Bonobo Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl NHGRI_mPanPan1-v2 1 189,129,491 - 189,146,874 (-) NCBI NHGRI_mPanPan1-v2 NHGRI_mPanPan1 1 188,258,572 - 188,275,955 (-) NCBI NHGRI_mPanPan1 Mhudiblu_PPA_v0 1 36,965,470 - 36,982,761 (+) NCBI Mhudiblu_PPA_v0 Mhudiblu_PPA_v0 panPan3 PanPan1.1 1 38,314,597 - 38,331,625 (+) NCBI panpan1.1 PanPan1.1 panPan2 PanPan1.1 Ensembl 1 38,314,597 - 38,331,625 (+) Ensembl panpan1.1 panPan2
CDCA8 Dog Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl CanFam3.1 15 4,796,980 - 4,809,914 (-) NCBI CanFam3.1 CanFam3.1 canFam3 CanFam3.1 CanFam3.1 Ensembl 15 4,798,197 - 4,809,658 (-) Ensembl CanFam3.1 canFam3 CanFam3.1 Dog10K_Boxer_Tasha 15 5,044,396 - 5,057,330 (-) NCBI Dog10K_Boxer_Tasha ROS_Cfam_1.0 15 4,931,395 - 4,944,330 (-) NCBI ROS_Cfam_1.0 ROS_Cfam_1.0 Ensembl 15 4,931,471 - 4,944,307 (-) Ensembl ROS_Cfam_1.0 Ensembl UMICH_Zoey_3.1 15 4,790,802 - 4,803,734 (-) NCBI UMICH_Zoey_3.1 UNSW_CanFamBas_1.0 15 4,857,151 - 4,870,085 (-) NCBI UNSW_CanFamBas_1.0 UU_Cfam_GSD_1.0 15 4,873,734 - 4,886,669 (-) NCBI UU_Cfam_GSD_1.0
Cdca8 Squirrel Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl HiC_Itri_2 NW_024405058 54,070,308 - 54,086,901 (+) NCBI HiC_Itri_2 SpeTri2.0 Ensembl NW_004936474 19,895,640 - 19,912,933 (+) Ensembl SpeTri2.0 SpeTri2.0 Ensembl SpeTri2.0 NW_004936474 19,895,681 - 19,912,451 (+) NCBI SpeTri2.0 SpeTri2.0 SpeTri2.0
CDCA8
CDCA8 Green Monkey Assembly Chr Position (strand) Source Genome Browsers JBrowse NCBI UCSC Ensembl ChlSab1.1 20 95,151,814 - 95,169,111 (-) NCBI ChlSab1.1 ChlSab1.1 chlSab2 ChlSab1.1 Ensembl 20 95,151,752 - 95,169,033 (-) Ensembl ChlSab1.1 ChlSab1.1 Ensembl chlSab2 Vero_WHO_p1.0 NW_023666033 21,640,702 - 21,658,296 (+) NCBI Vero_WHO_p1.0 Vero_WHO_p1.0
Cdca8
.
Predicted Target Of
Count of predictions: 88 Count of miRNA genes: 78 Interacting mature miRNAs: 83 Transcripts: ENSRNOT00000048293 Prediction methods: Miranda, Rnahybrid, Targetscan Result types: miRGate_prediction
1331796 Thshl2 Thyroid stimulating hormone level QTL 2 2.3 blood thyroid-stimulating hormone amount (VT:0005119) serum thyroid stimulating hormone level (CMO:0001248) 5 97059760 147465714 Rat 10053720 Scort26 Serum corticosterone level QTL 26 2.06 0.0147 blood corticosterone amount (VT:0005345) plasma corticosterone level (CMO:0001173) 5 124965598 166875058 Rat 1549845 Scl44 Serum cholesterol level QTL 44 6 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 5 40128307 148607290 Rat 8552960 Pigfal15 Plasma insulin-like growth factor 1 level QTL 15 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 5 111416838 156416838 Rat 631562 Apr2 Acute phase response QTL 2 3.7 blood murinoglobulin 1 amount (VT:0010597) plasma murinoglobulin 1 level (CMO:0001931) 5 135927956 166875058 Rat 61444 Strs2 Sensitivity to stroke QTL 2 4.7 cerebrum integrity trait (VT:0010549) post-insult time to onset of cerebrovascular lesion (CMO:0002343) 5 135929696 166875058 Rat 1300122 Wbc1 White blood cell count QTL 1 2.75 leukocyte quantity (VT:0000217) total white blood cell count (CMO:0000365) 5 125392826 139989768 Rat 61452 Ciaa5 CIA Autoantibody QTL 5 3.5 blood autoantibody amount (VT:0003725) calculated serum anti-rat type 2 collagen autoantibody titer (CMO:0001281) 5 94858972 143070159 Rat 70156 Niddm30 Non-insulin dependent diabetes mellitus QTL 30 3.98 blood glucose amount (VT:0000188) blood glucose level area under curve (AUC) (CMO:0000350) 5 129132447 151006154 Rat 8552908 Pigfal4 Plasma insulin-like growth factor 1 level QTL 4 6.6 blood insulin-like growth factor amount (VT:0010479) plasma insulin-like growth factor 1 level (CMO:0001299) 5 128506074 166875058 Rat 1331803 Rf32 Renal function QTL 32 2.798 kidney blood vessel physiology trait (VT:0100012) absolute change in renal vascular resistance (CMO:0001900) 5 129132428 143070159 Rat 61393 Bp7 Blood pressure QTL 7 4.5 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 60293434 161481680 Rat 7794791 Mcs33 Mammary carcinoma susceptibility QTL 33 1.93 mammary gland integrity trait (VT:0010552) mammary tumor incidence/prevalence measurement (CMO:0000946) 5 131345754 166875058 Rat 7207486 Bss109 Bone structure and strength QTL 109 femur strength trait (VT:0010010) femur total energy absorbed before break (CMO:0001677) 5 106906205 151906205 Rat 7207481 Bss106 Bone structure and strength QTL 106 7.9 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 5 106906205 151906205 Rat 1302790 Scl20 Serum cholesterol level QTL 20 6.4 0.0001 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 82394392 166664054 Rat 1598861 Cm64 Cardiac mass QTL 64 2.9 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 5 127798274 166875058 Rat 1578766 Tcas11 Tongue tumor susceptibility QTL 11 4.12 tongue integrity trait (VT:0010553) number of squamous cell tumors of the tongue with diameter greater than 3 mm (CMO:0001950) 5 46711509 161317411 Rat 631505 Bp103 Blood pressure QTL 103 3.2 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 132717196 165560427 Rat 1549838 Bss4 Bone structure and strength QTL 4 9.2 femur strength trait (VT:0010010) femur midshaft polar moment of inertia (CMO:0001669) 5 106906205 151906205 Rat 1641920 Colcs1 Colorectal carcinoma susceptibility QTL 1 2.99 0.0055 intestine integrity trait (VT:0010554) benign colorectal tumor surface area measurement (CMO:0001799) 5 121846814 166846814 Rat 8694169 Bw148 Body weight QTL 148 5 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 5 128506074 166875058 Rat 8657050 Bw146 Body weight QTL 146 19.84 0.001 body mass (VT:0001259) body weight gain (CMO:0000420) 5 108938288 153938288 Rat 1581510 Cm54 Cardiac mass QTL 54 3.4 0.05 heart left ventricle mass (VT:0007031) heart left ventricle weight to body weight ratio (CMO:0000530) 5 120740824 143608494 Rat 1576312 Emca8 Estrogen-induced mammary cancer QTL 8 4.1 mammary gland integrity trait (VT:0010552) mammary tumor number (CMO:0000343) 5 50328551 141643988 Rat 1641912 Alcrsp18 Alcohol response QTL 18 response to alcohol trait (VT:0010489) duration of loss of righting reflex (CMO:0002289) 5 35189153 141643988 Rat 1576314 Eutr1 Estrogen induced uterine response QTL 1 uterus integrity trait (VT:0010575) pyometritis severity score (CMO:0002009) 5 2138965 166875058 Rat 2317056 Wbc3 White blood cell count QTL 3 2.51 0.01 leukocyte quantity (VT:0000217) white blood cell count (CMO:0000027) 5 105999803 150999803 Rat 634349 Bp139 Blood pressure QTL 139 0.001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 128924607 166875058 Rat 724525 Bp147 Blood pressure QTL 147 4.3 0.0001 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 126424772 166875058 Rat 1598847 Cm62 Cardiac mass QTL 62 3.4 heart mass (VT:0007028) heart weight to body weight ratio (CMO:0000074) 5 108845856 153845856 Rat 2293642 Bss37 Bone structure and strength QTL 37 4.64 0.0001 femur strength trait (VT:0010010) femur ultimate force (CMO:0001675) 5 120740824 151018848 Rat 1578673 Bmd13 Bone mineral density QTL 13 4.9 femur mineral mass (VT:0010011) trabecular volumetric bone mineral density (CMO:0001729) 5 103689353 148689353 Rat 738018 Anxrr4 Anxiety related response QTL 4 5.1 exploratory behavior trait (VT:0010471) percentage of entries into a discrete space in an experimental apparatus (CMO:0000961) 5 130130159 166875058 Rat 7207488 Bss110 Bone structure and strength QTL 1 8.4 femur strength trait (VT:0010010) femur stiffness (CMO:0001674) 5 106906205 151906205 Rat 8694441 Bw169 Body weight QTL 169 17.61 0.001 retroperitoneal fat pad mass (VT:0010430) retroperitoneal fat pad weight to body weight ratio (CMO:0000635) 5 111416838 156416838 Rat 7207491 Bss112 Bone structure and strength QTL 112 7 femur morphology trait (VT:0000559) femur midshaft cortical cross-sectional area (CMO:0001663) 5 106906205 151906205 Rat 8694389 Bw160 Body weight QTL 160 6.17 0.001 body lean mass (VT:0010483) lean tissue morphological measurement (CMO:0002184) 5 111416838 156416838 Rat 61426 Scl2 Serum cholesterol level QTL 2 7.3 0.001 blood cholesterol amount (VT:0000180) serum total cholesterol level (CMO:0000363) 5 59793399 143070159 Rat 1354598 Srn6 Serum renin concentration QTL 6 3.8 blood renin amount (VT:0003349) plasma renin activity level (CMO:0000116) 5 69540295 151018848 Rat 8694198 Abfw3 Abdominal fat weight QTL 3 16.13 0.001 visceral adipose mass (VT:0010063) abdominal fat pad weight to body weight ratio (CMO:0000095) 5 111416838 156416838 Rat 1298089 Scl14 Serum cholesterol level QTL 14 5.8 0.0004 blood cholesterol amount (VT:0000180) plasma total cholesterol level (CMO:0000585) 5 108845856 153845856 Rat 1598819 Bp292 Blood pressure QTL 292 4.3 arterial blood pressure trait (VT:2000000) systolic blood pressure (CMO:0000004) 5 127798274 166875058 Rat 7411722 Strs6 Sensitivity to stroke QTL 6 3.9 cerebrum integrity trait (VT:0010549) percentage of study population developing cerebrovascular lesions during a period of time (CMO:0000932) 5 134972980 138113556 Rat 1358187 Emca1 Estrogen-induced mammary cancer QTL 1 4.4 mammary gland integrity trait (VT:0010552) post-insult time to mammary tumor formation (CMO:0000345) 5 99216724 148607142 Rat
Click on a value in the shaded box below the category label to view a detailed expression data table for that system.
alimentary part of gastrointestinal system
9
11
49
113
91
90
59
25
59
6
218
97
93
45
60
31
Too many to show, limit is 500. Download them if you would like to view them all.
Ensembl Acc Id:
ENSRNOT00000048293 ⟹ ENSRNOP00000043633
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source mRatBN7.2 Ensembl 5 137,176,417 - 137,198,629 (-) Ensembl Rnor_6.0 Ensembl 5 142,911,305 - 142,933,526 (-) Ensembl
RefSeq Acc Id:
NM_001025050 ⟹ NP_001020221
RefSeq Status:
PROVISIONAL
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 142,461,087 - 142,483,199 (-) NCBI mRatBN7.2 5 137,176,419 - 137,198,532 (-) NCBI Rnor_6.0 5 142,911,319 - 142,933,431 (-) NCBI Rnor_5.0 5 146,680,981 - 146,700,067 (-) NCBI RGSC_v3.4 5 144,251,164 - 144,276,352 (-) RGD Celera 5 135,697,190 - 135,716,709 (-) RGD
Sequence:
CCGCAGAGTTCAGGATACCTAGACTCCAACGACTGAACTTCCGCTGCTCCCCGACCACTCACGCCCTCTTTCCCGGTCTCATTCGCTAACCCGGCAGCTCGGCCCCTCGCTGGACGCACCCTGGTGTC
hide sequence
RefSeq Acc Id:
XM_008764064 ⟹ XP_008762286
Type:
CODING
Position:
Rat Assembly Chr Position (strand) Source GRCr8 5 142,461,082 - 142,483,336 (-) NCBI mRatBN7.2 5 137,176,414 - 137,198,686 (-) NCBI Rnor_6.0 5 142,911,310 - 142,933,536 (-) NCBI
Sequence:
TGCCCGTTGAGTTTGAATTGGGTGGCGGTTAGTGGAAGATCAACCCGTCCCTCAGCTGGAGCTG
hide sequence
RefSeq Acc Id:
NP_001020221 ⟸ NM_001025050
- UniProtKB:
Q6AXW0 (UniProtKB/Swiss-Prot)
- Sequence:
MAPKKRSSRGTRTNTLRSRKLASFLKDFDREVQVRTKQIESDRQTLLKEVENLYNIEVLRLPKALQVMKWLDYFALGGNRQALEEAATADRDITEINNLTAEAIQTPLKSVKKRKVIEVDEAIKEEEE
hide sequence
RefSeq Acc Id:
XP_008762286 ⟸ XM_008764064
- Peptide Label:
isoform X1
- UniProtKB:
Q6AXW0 (UniProtKB/Swiss-Prot)
- Sequence:
MAPKKRSSRGTRTNTLRSRKLASFLKDFDREVQVRTKQIESDRQTLLKEVENLYNIEVLRLPKA
hide sequence
Ensembl Acc Id:
ENSRNOP00000043633 ⟸ ENSRNOT00000048293
RGD ID: 13694018 Promoter ID: EPDNEW_R4541 Type: multiple initiation site Name: Cdca8_1 Description: cell division cycle associated 8 SO ACC ID: SO:0000170 Source: EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/ ) Experiment Methods: Single-end sequencing. Position: Rat Assembly Chr Position (strand) Source Rnor_6.0 5 142,933,503 - 142,933,563 EPDNEW
Date
Current Symbol
Current Name
Previous Symbol
Previous Name
Description
Reference
Status
2006-02-09
Cdca8
cell division cycle associated 8
Symbol and Name status set to provisional
70820 PROVISIONAL
